Publication Topic

Kaetzel R, Wagner M, Sweeney L, Duggan A, Gargas M, Teta MJ. An evaluation of early-life susceptibility and exposures to ethylene oxide. Presented at the Society of Toxicology Conference, Charlotte, NC, March 2007

Kulpa-Eddy J, Jacobs AC, Halder M, Burns TA, Choksi NY, Allen DG, Tice RR, Stokes WS. Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)/National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM)/European Centre for the Validation of Alternative Methods (ECVAM) workshop on alternative methods to refine, reduce, and replace the mouse LD50 assay for botulinum toxin testing. Poster presented at Society of Toxicology Annual Meeting, Charlotte, NC, March 2007.

Choksi NY, Haseman JK, Truax JF, Charles JM, Wnorowski G, Merkel D, Stokes WS. Effect of topical anesthetic pretreatment on in vivo ocular irritation hazard classification. Poster presented at Society of Toxicology Annual Meeting, Charlotte, NC, March 2007.

Haws, L.C., L.L.F. Scott, D.F. Staskal, M.A. Harris, and B.L. Finley. Dioxin-like compounds in workers at a primary magnesium production facility. Dioxin 2008, Tokyo, Japan, 2007.

Gentry PR, Covington TR, Lawrence G, McDonald T, Snow ET, Germolec D, Moser G, Yager JW, Clewell HJ III. 2005. Comparison of tissue dosimetry in the mouse following chronic exposure to arsenic compounds. J Toxicol Environ Health A 68:329–351.

Covington TR, Gentry PR, Van Landingham CB, Andersen ME, Kester JE, Clewell HJ. 2007. The use of Markov chain MonteCarlo uncertainty analysis to support a Public Health Goal for perchloroethylene. Regul Toxicol Pharmacol 47(1):1–18.

Hinerman J, Mueser T. Protein-protein interactions between bacteriophage T4 helicase assembly protein and single-stranded DNA binding protein. Poster presented to Ohio Crystallographic Symposium Meeting, University of Toledo, Toledo, OH, fall 2007.

Haws LC, Scott LLF, Staskal D, Harris M, Finley B. Evaluation of biomonitoring data for dioxin-like compounds in workers at a primary magnesium production facility. Society for Risk Analysis Annual Meeting, San Antonio, TX, 2007.

Haws LC, Walker NJ, DeVito MJ, Birnbaum LS, Unice KM, Scott PK, Harris MA, Farland WH, Finley BL, Staskal DF. Development of weighted distributions of REPs for dioxin-like compounds (DLCs). Society of Toxicology Annual Meeting, Charlotte, NC, 2007/

Staskal, DF, Donovan EP, Haws LC, Roberts JD, Unice KM, Finley BL, Harris MA. A quantitative microbial risk assessment for exposure to pathogens in waters and sediments of the Lower Passaic River. Society for Risk Analysis Annual Meeting, San Antonio, TX, 2007.

Staskal DF, Donovan E, Roberts J, Unice K, Finley B, Harris M. Human health risk associated with exposure to pathogen-contaminated sediments. Society of Toxicology 46th Annual Meeting, Charlotte, NC, 2007.

Subramaniam RP, Crump KS, Chen C, White P, Van Landingham C, Fox JF, Schlosser P, Covington TR, et al. The role of mutagenicity in describing formaldehyde-induced carcinogenicity: Possible inferences using the CIIT model. Presentation at the Annual Society for Risk Analysis Conference, Baltimore, MD, December 2006.

Crump KS, Subramaniam R, White P, Chen C, Schlosser P, Van Landingham C, Covington TR, DeVoney D. Consideration of uncertainties in the CIIT model for formaldehyde carcinogenicity in the human respiratory tract. Presentation at the Annual Society for Risk Analysis Conference, Baltimore, MD, December 2006.

Watson RE, DeSesso JM, Hurtt ME, Cappon GD. 2006. Postnatal growth and morphological development of the brain: A species comparison. Birth Defects Res (Part B) 77:471–484, DOI: 10.1002/bdrb.20090, online article.

Robison SH, Greggs W, Hochwalt AE, Kohrman K, Kosemund K, McMillan DA, Naciff JN. Diethyl phthalate — Biomonitoring based risk assessment. Toxicologist 90:257 (Abstract 1260), 2006.

Mahony C, Felter SP, McMillan DA. 2006. An exposure-based risk assessment approach to confirm the safety of hydrogen peroxide for use in home tooth bleaching. Regul Toxicol Pharmacol 44:75–82.

Teeguarden JG, Dorman DC, Nong A, Covington TR, Clewell HJ III, Andersen ME. 2007. Pharmacokinetic modeling of manganese. II. Hepatic processing after ingestion and inhalation. J Toxicol Environ Health A 70:1505–1514.

Teeguarden JG, Dorman DC, Covington TR, Clewell HJ III, Andersen ME. 2007. Pharmacokinetic modeling of manganese. I. Dose dependencies of uptake and elimination. J Toxicol Environ Health A 70:1493–1504.

Paustenbach DJ, Gaffney SA, Scott PK, Brown JL, Panko JM. High background levels of urinary benzene metabolites found in volunteer study. Society of Toxicology Conference 2006.

Paustenbach DJ, Panko JM, Scott PK, Unice KM. Retrospective modeling of potential residential exposure to perfluorooctanoic acid (PFOA) releases from a manufacturing facility. Society of Toxicology Conference 2006.